Under construction – not a live service
Sign in
Taking peopleNo phase

Physical Activity Added to CPAP for Blood Pressure in Sleep Apnea

Tests exercise added to CPAP in adults with sleep apnea and hard-to-control high blood pressure.

Plain-language title generated from the registry record
Registry title: Physical Activity Program for Reducing Blood Pressure in Sleep Apnea Patients With Resistant Hypertension

Key facts

Where
Geneva and Lausanne, SwitzerlandSee the 2 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Source: NCT02057783, who can take part

Where in Switzerland

  • Hôpitaux universitaires de GenèveGeneva, SwitzerlandNo longer taking part
  • Centre Hospitalier Universitaire VaudoisLausanne, SwitzerlandNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
AGIR à Dom
Trial code
NCT02057783
Record updated
20 February 2025
Original description
Investigators hypothesize that CPAP treatment for suppressing OSAS in combination with a physical activity program will optimize 24-hour blood pressure control in patients with OSA-related resistant hypertension.Read full original descriptionShow less

Comparison of Standard Treatment by Continuous Positive Airway Pressure (CPAP) and CPAP Combined to a Physical Activity Program for Reducing Blood Pressure in Sleep Apnea Patients With Resistant Hypertension: RAP Randomized Controlled Trial

Investigators hypothesize that CPAP treatment for suppressing OSAS in combination with a physical activity program will optimize 24-hour blood pressure control in patients with OSA-related resistant hypertension.

Inclusion: Patient with an obstructive sleep apnea (apnea-hypopnea index > or equal to 15); Patient with resistant hypertension uncontrolled by 3 or more antihypertensive agents; Ambulatory patient.

Exclusion: Acute hepatic failure, biliary cirrhosis, cholestasis; Acute hypertension (SBP>= 180 mmHg and/or DBP >= 110 mmHg); Contraindication to CPAP treatment.

ClinicalTrials.gov NCT02057783